Penn Nanotoxicology Alliance-Pilot Projects

The Penn Nanotoxicology Alliance consists of the Center of Excellence in Environmental Toxicology (CEET), the Targeted Therapeutics and Nanomedicine Program of the ITMAT/CTSA, the Nanotechnology Institute (NTI), and the Nano-Bio Interface Center.  

To jump-start nanotoxicology initiatives, we are pleased to announce this new program to support Pilot Projects in Nanotoxicology. We seek proposals for 12-month seed efforts that address any relevant research topic related to the toxicology of nanoparticles and nanostructured materials. Projects that characterize the physical and chemical properties of engineered nanoparticles, explore their basic biology and pathobiology, and provide a clear pathway to the clinical and commercial deployment of environmentally safe nanoparticles are particularly encouraged, as are projects that have the potential to generate new or develop existing intellectual property.

Follow this link to the application:  CEET Solicitation Nanotoxicology 2010.

For more information contact:
Mary E. Webster. M.S.
Center of Excellence in Environmental Toxicology
wesbter (at) mail.med.upenn.edu

Why Is Small So Big?

Nanotechnology deals with products and processes that are measured in almost unbelievably small increments called “nanometers”—one billionth of a meter.

At the nanoscale, materials differ from larger objects in their physical, chemical and biological properties; therefore, they lend themselves to new and improved materials, systems and devices. Nanotechnology is behind the development of such diverse advancements as:

  1. Drug Delivery
  2. Biofiltration and Separation sciences
  3. Improved coatings for medical devices

Thanks to rapid advances in this exciting new field, we now have the tools and talents to manipulate materials on the molecular scale—a technology literally changing the world as we know it.